PURPOSE: We retrospectively reviewed the treatment outcomes of extracorporeal shockwave lithotripsy (SWL) in a single center using either the Wolf Piezolith 2300 (a piezoelectric lithotripter), the Dornier MPL9000 (an electrohydraulic lithotripter), or the Dornier Compact Delta (an electromagnetic lithotripter) from January 1992 to June 2002. PATIENTS AND METHODS: A series of 3123 (1449 Piezolith 2300, 780 MPL9000, and 894 Compact Delta) solitary radiopaque urinary stones of < or =15 mm receiving primary SWL were identified. "Stone free" was defined as the absence of evidence of stone on plain radiography. Treatment outcomes were assessed by the stone-free rate 3 months after one treatment session, the retreatment rate, the auxiliary procedure rate, the complication rate, and the effectiveness quotient (EQ). In order to have a better assessment of the efficacy of individual lithotripters, multiple logistic regression was performed to control various factors affecting treatment outcomes, including lithotripter-type, patients' sex and age, history of previous SWL, the stone characteristics (side, site, and size), and the presence of a stent or nephrostomy tube. RESULTS: There were significant differences in the stone site distribution and mean stone size among the three groups. The overall EQ for the Piezolith 2300, MPL9000, and Compact Delta were 0.345, 0.303, and 0.257, respectively. However, using the multiple logistic regression model, the adjusted odds ratio (AOR) of a patient being stone-free after 3 month for the Piezolith 2300 and MPL9000 (using the Compact Delta as the referent category) were 1.38 (95% CI 1.15, 1.65) and 1.72 (95% CI 1.39, 2.11), respectively. Patients treated using the MPL9000 had significantly less re-treatment (AOR = 0.57; 95% CI 0.48, 0.69) than the other groups. No significant difference in the auxiliary procedure rate and complication rate for the three machines was observed. CONCLUSION: Based on multivariate analysis results, the Dornier MPL9000 had the best treatment outcomes in terms of stone-free rate and re-treatment rate among the three lithotripters.
PURPOSE: We retrospectively reviewed the treatment outcomes of extracorporeal shockwave lithotripsy (SWL) in a single center using either the Wolf Piezolith 2300 (a piezoelectric lithotripter), the Dornier MPL9000 (an electrohydraulic lithotripter), or the Dornier Compact Delta (an electromagnetic lithotripter) from January 1992 to June 2002. PATIENTS AND METHODS: A series of 3123 (1449 Piezolith 2300, 780 MPL9000, and 894 Compact Delta) solitary radiopaque urinary stones of < or =15 mm receiving primary SWL were identified. "Stone free" was defined as the absence of evidence of stone on plain radiography. Treatment outcomes were assessed by the stone-free rate 3 months after one treatment session, the retreatment rate, the auxiliary procedure rate, the complication rate, and the effectiveness quotient (EQ). In order to have a better assessment of the efficacy of individual lithotripters, multiple logistic regression was performed to control various factors affecting treatment outcomes, including lithotripter-type, patients' sex and age, history of previous SWL, the stone characteristics (side, site, and size), and the presence of a stent or nephrostomy tube. RESULTS: There were significant differences in the stone site distribution and mean stone size among the three groups. The overall EQ for the Piezolith 2300, MPL9000, and Compact Delta were 0.345, 0.303, and 0.257, respectively. However, using the multiple logistic regression model, the adjusted odds ratio (AOR) of a patient being stone-free after 3 month for the Piezolith 2300 and MPL9000 (using the Compact Delta as the referent category) were 1.38 (95% CI 1.15, 1.65) and 1.72 (95% CI 1.39, 2.11), respectively. Patients treated using the MPL9000 had significantly less re-treatment (AOR = 0.57; 95% CI 0.48, 0.69) than the other groups. No significant difference in the auxiliary procedure rate and complication rate for the three machines was observed. CONCLUSION: Based on multivariate analysis results, the Dornier MPL9000 had the best treatment outcomes in terms of stone-free rate and re-treatment rate among the three lithotripters.
Authors: Stuart Roy Faragher; Robin O Cleveland; Sunil Kumar; Oliver J Wiseman; Benjamin W Turney Journal: J Endourol Date: 2016-02-26 Impact factor: 2.942
Authors: Bret A Connors; James A McAteer; Andrew P Evan; Philip M Blomgren; Rajash K Handa; Cynthia D Johnson; Sujuan Gao; Yuri A Pishchalnikov; James E Lingeman Journal: BJU Int Date: 2012-04-23 Impact factor: 5.588
Authors: Yuri A Pishchalnikov; James A McAteer; James C Williams; Bret A Connors; Rajash K Handa; James E Lingeman; Andrew P Evan Journal: J Endourol Date: 2013-02-06 Impact factor: 2.942
Authors: Naeem Bhojani; Jessica A Mandeville; Tariq A Hameed; Trevor M Soergel; James A McAteer; James C Williams; Amy E Krambeck; James E Lingeman Journal: J Urol Date: 2014-10-08 Impact factor: 7.450
Authors: Eduardo Mazzucchi; Artur H Brito; Alexandre Danilovic; Gustavo X Ebaid; Elias Chedid Neto; José Reinaldo Franco de Azevedo; Miguel Srougi Journal: Clinics (Sao Paulo) Date: 2010 Impact factor: 2.365